Cargando…

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis

BACKGROUND: Some studies have reported that renal dysfunction is associated with poor prognosis in cirrhotic patients. Serum cystatin C (CysC) is an accurate biomarker for early renal dysfunction. This study aimed to assess the prognostic value of serum CysC levels in patients with hepatitis B virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, JianPing, Wu, QianXia, Wu, MinYi, Mao, WeiLin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425319/ https://www.ncbi.nlm.nih.gov/pubmed/30949507 http://dx.doi.org/10.1155/2019/7272045

Ejemplares similares

Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2020)

D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis
por: Sun, Lin, et al.
Publicado: (2022)

New prognostic factor for hepatitis B virus‐related decompensated cirrhosis: Ratio of monocytes to HDL‐cholesterol
por: Wu, Qianxia, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis
por: Zhang, Honggang, et al.
Publicado: (2016)

Serum potassium levels and prognosis in HBV‐associated decompensated cirrhosis
por: Huang, JianJiang, et al.
Publicado: (2021)

Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis
por: Zhu, ShaoMing, et al.
Publicado: (2017)

Cystatin C and interleukin‐6 for prognosticating patients with acute decompensation of cirrhosis
por: Padia, Gaurav, et al.
Publicado: (2021)

Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases
por: Wu, JianPing, et al.
Publicado: (2020)

Platelet‐to‐white blood cell ratio: A novel and promising prognostic marker for HBV‐associated decompensated cirrhosis
por: Zhang, JinFei, et al.
Publicado: (2020)

Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis
por: Zhou, Jing, et al.
Publicado: (2019)

Evaluation of the neutrophil‐to‐lymphocyte ratio, monocyte‐to‐lymphocyte ratio, and red cell distribution width for the prediction of prognosis of patients with hepatitis B virus‐related decompensated cirrhosis
por: Li, XinKe, et al.
Publicado: (2020)

Identification of potential metabolite markers for colon cancer and rectal cancer using serum metabolomics
por: Wu, Jianping, et al.
Publicado: (2020)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis
por: Mao, Weilin, et al.
Publicado: (2016)

Neutrophil count to albumin ratio as a prognostic indicator for HBV‐associated decompensated cirrhosis
por: Han, Zhong, et al.
Publicado: (2021)

Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure
por: Wan, Zhihong, et al.
Publicado: (2015)

Increased Serum Levels of sCD206 Are Associated with Adverse Prognosis in Patients with HBV-Related Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2022)

Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Mortality in Patients with HBV-Related Decompensated Cirrhosis
por: Yu, Ze, et al.
Publicado: (2022)

Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis
por: Suksamai, Anuchit, et al.
Publicado: (2021)

Low Prealbumin Levels Were Associated with Increased Frequency of Hepatic Encephalopathy in Hepatitis B Virus (HBV)-Related Decompensated Cirrhosis
por: Li, Jiani, et al.
Publicado: (2023)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
por: Li, Mingyu, et al.
Publicado: (2023)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
por: Zhu, Dong-Mei, et al.
Publicado: (2020)

Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis
por: Rachakonda, Vikrant, et al.
Publicado: (2016)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
por: Wang, Tongyu, et al.
Publicado: (2022)

Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis
por: Guo, Gaoyue, et al.
Publicado: (2022)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
por: Omar, Mahmoud, et al.
Publicado: (2015)

Evaluation of five lymphocyte-based scores for prediction of mortality in hepatitis B virus-associated decompensated cirrhosis
por: Mao, Ting, et al.
Publicado: (2023)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
por: Mao, Hao-dan, et al.
Publicado: (2023)

Reference Intervals for Serum Cystatin C and Factors Influencing Cystatin C Levels Other than Renal Function in the Elderly
por: Wei, Lu, et al.
Publicado: (2014)

Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy
por: Wu, Shi-Lan, et al.
Publicado: (2018)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2017)

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
por: Li, Miaomiao, et al.
Publicado: (2020)

Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis
por: Grace, Josephine A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p24ij9d8n0u12g8mpjo503dfil